AMRX.OQ - Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc
Truist SecuritiesRecommendation Increase, Price Target Increase

AMRX - Mgmt Fine Tuning The Biz For EBITDA Growth To Outpace Sales; Reit BUY And Raise PT To $17 (From $15)

公司
AMRX.OQ
日期
2026-02-27
分析师
Mr. Les Sulewski
页数
11
需要登录
请登录后购买研报或生成音频内容。